CoinVoice has learned that, according to The Block, Coeptis Therapeutics will merge with Z Squared, which focuses on Dogecoin Mining, and plans to rename itself as Z Squared, officially transforming from a biopharmaceutical company to a digital asset Mining enterprise. This merger will include the acquisition of 9,000 Dogecoin Mining Rigs and the divestiture of the original biopharmaceutical division.
Due to the impact of the latest news, Coeptis’s stock price plummeted nearly 40%, with a current market value of approximately $32 million. The new company will be led by Z Squared’s current CEO David Halabu and COO Michelle Burke, with the goal of creating the largest publicly traded Dogecoin Mining company in the United States.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Coeptis announced its merger with Z Squared, transforming into a digital asset mining company.
CoinVoice has learned that, according to The Block, Coeptis Therapeutics will merge with Z Squared, which focuses on Dogecoin Mining, and plans to rename itself as Z Squared, officially transforming from a biopharmaceutical company to a digital asset Mining enterprise. This merger will include the acquisition of 9,000 Dogecoin Mining Rigs and the divestiture of the original biopharmaceutical division.
Due to the impact of the latest news, Coeptis’s stock price plummeted nearly 40%, with a current market value of approximately $32 million. The new company will be led by Z Squared’s current CEO David Halabu and COO Michelle Burke, with the goal of creating the largest publicly traded Dogecoin Mining company in the United States.